THE OVARIAN ACTION OF INTERLEUKIN-1 IS RECEPTOR-MEDIATED - REVERSAL BY A NATURALLY-OCCURRING INTERLEUKIN-1 RECEPTOR ANTAGONIST

被引:10
|
作者
KOKIA, E [1 ]
BENSHLOMO, I [1 ]
ADASHI, EY [1 ]
机构
[1] UNIV MARYLAND,SCH MED,DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL,BALTIMORE,MD 21201
关键词
INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR ANTAGONIST; OVARY; GRANULOSA; PROSTAGLANDINS;
D O I
10.1016/S0015-0282(16)57314-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To address indirectly the possibility that the ovarian action(s) of interleukin (IL)-1 are receptor mediated and to re-examine the recently reported proposition that the naturally occurring IL-1 receptor antagonist (IL-1ra) may in fact act in the capacity of mixed IL-1 receptor agonist/antagonist. Design: In vitro treatment of isolated granulosa cell (GC) and whole ovarian dispersates of rat origin. Results: Treatment of GC from immature rats with increasing concentrations of IL-1ra (10 to 5,000 ng/mL) proved without effect on either the basal or FSH (100 ng/mL)-supported accumulation of P. Likewise, cellular viability (as assessed by conversion of 3-[4,5-dimethylthiazol-2-yl]-2-5 diphenyltetrazolium bromide to spectrophotometrically detectable formazan) remained unaltered. However, the concomitant addition of increasing concentrations of IL-1ra (10 to 5,000 ng/mL) yielded dose-dependent reversal of the 10 ng/mL IL-1 beta-mediated inhibition of the FSH-supported accumulation of P. Similarly, the ability of IL-1 beta to exert a dose-dependent (0 to 30 ng/mL) antigonadotropic effect was attenuated progressively given the concurrent presence of increasing concentrations (1,000 and 5,000 ng/mL) of IL-1ra. Although treatment of whole ovarian dispersates with 10 ng/mL IL-1 beta resulted in a 5.4-fold increase in the accumulation of prostaglandin (PG)E(2), this effect too was all but eliminated after the concomitant addition of 5 mu g/mL IL-1ra. Conclusions: These observations support the nontoxic nature of IL-1ra, confirm its lack of agonistic activity, validate its utility as an experimental probe, and suggest that neither the basal nor the FSH-stimulated accumulation of P are subject to regulation by endogenously produced GC-derived IL-1-like activity. Moreover, these observations suggest that the ability of IL-1 beta to inhibit the gonadotropin-supported accumulation of P and to increase PGE(2) accumulation is receptor-mediated.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 50 条
  • [1] INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    ESPAT, NJ
    ROGY, MA
    COPELAND, EM
    MOLDAWER, LL
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (02) : 393 - 400
  • [2] INTERLEUKIN-1 AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
    DINARELLO, CA
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1991, 372 (04): : 239 - 239
  • [3] Interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    NUTRITION, 1995, 11 (05) : 492 - 494
  • [4] INTERLEUKIN-1 RECEPTOR ANTAGONIST INHIBITS THE HYPERCALCEMIA MEDIATED BY INTERLEUKIN-1
    GUISE, TA
    GARRETT, IR
    BONEWALD, LF
    MUNDY, GR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 (05) : 583 - 587
  • [5] Graves' ophthalmopathy and gene polymorphisms in interleukin-1α, interleukin-1β, interleukin-1 receptor and interleukin-1 receptor antagonist
    Khalilzadeh, Omid
    Anvari, Mehdi
    Esteghamati, Alireza
    Mahmoudi, Mahdi
    Tahvildari, Maryam
    Rashidi, Armin
    Khosravi, Farideh
    Amirzargar, Aliakbar
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (06): : 614 - 619
  • [6] Induction of interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 981 - 993
  • [7] The role of the interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1
    Dinarello, CA
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (10): : 732 - 734
  • [8] Balance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in the Development of Atherosclerosis - A Polymorphism in the Interleukin-1 Receptor Antagonist -
    Iida, Shinichiro
    Komiyama, Nobuyuki
    CIRCULATION JOURNAL, 2009, 73 (08) : 1401 - 1402
  • [9] Interleukin-1 Receptor Antagonist
    Lennard, Andrew C.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2017, 37 (2-6) : 531 - 559
  • [10] Interleukin-1 receptor antagonist
    Bresnihan, B
    Cunnane, G
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) : 615 - +